glp-1 long term effects of agonists Impact GLP- 1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia Psychological and behavioral effects of

Int J Syst Evol Microbiol 70(4):27822858

Repeated exposure to microcystin-leucine-arginine potentiates excitotoxicity induced by a low dose of kainate

Because of its defined peptide sequence and stable analytical profile, FOXO4-DRI has become a reference compound in experimental cellular ageing and protein interaction research models

This editorial highlights the lack of uptake of diagnostic tests to identify inflammation of the airways in patients with asthma in both diagnosis and long-term management, which leads to suboptimal disease control

This dual GIP/GLP-1 receptor agonist is administered as a once-weekly subcutaneous injection and must be obtained through legitimate healthcare channels